Table 2.
Inclusion criteria | Exclusion criteria |
---|---|
Age 18–90-year-old men or women Signed informed consent for CH-EUS, EH-EUS, and FNA The diagnosis of pancreatic cancer histologically confirmed by FNA/clinical follow-up Unresectable, locally advanced, and/or metastatic disease Both pancreatic adenocarcinomas and pancreatic neuroendocrine tumors were included |
Previous chemotherapy or radiotherapy Resectable pancreatic tumors |
CH-EUS: Contrast-enhanced EUS